TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients.
TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients. Cardiooncology. 2021 Jun 28; 7(1):25.